Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/126499
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMargalef, Pol-
dc.contributor.authorFernández Majada, Vanessa-
dc.contributor.authorVillanueva Garatachea, Alberto-
dc.contributor.authorGarcia Carbonell, Ricard-
dc.contributor.authorIglesias, Mar-
dc.contributor.authorLópez, Laura-
dc.contributor.authorMartínez Iniesta, María-
dc.contributor.authorVillà Freixa, Jordi-
dc.contributor.authorMulero Roig, María Carmen-
dc.contributor.authorAndreu, Montserrat-
dc.contributor.authorTorres, Ferran-
dc.contributor.authorMayo, Marty W.-
dc.contributor.authorBigas Salvans, Anna-
dc.contributor.authorEspinosa, Lluis-
dc.date.accessioned2018-11-27T12:18:12Z-
dc.date.available2018-11-27T12:18:12Z-
dc.date.issued2012-10-04-
dc.identifier.urihttp://hdl.handle.net/2445/126499-
dc.description.abstractNuclear IKK alpha regulates gene transcription by phosphorylating specific substrates and has been linked to cancer progression and metastasis. However, the mechanistic connection between tumorigenesis and IKK alpha activity remains poorly understood. We have now analyzed 288 human colorectal cancer samples and found a significant association between the presence of nuclear IKK and malignancy. Importantly, the nucleus of tumor cells contains an active IKK alpha isoform with a predicted molecular weight of 45 kDa (p45-IKK alpha) that includes the kinase domain but lacks several regulatory regions. Active nuclear p45-IKK alpha forms a complex with nonactive IKK alpha and NEMO that mediates phosphorylation of SMRT and histone H3. Proteolytic cleavage of FL-IKK alpha into p45-IKK alpha is required for preventing the apoptosis of CRC cells in vitro and sustaining tumor growth in vivo. Our findings identify a potentially druggable target for treating patients with advance refractory CRC.-
dc.format.extent15 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherCell Press-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.celrep.2012.08.028-
dc.relation.ispartofCell Reports, 2012, vol. 2, num. 4, p. 840-854-
dc.relation.urihttps://doi.org/10.1016/j.celrep.2012.08.028-
dc.rightscc by (c) Margalef et al., 2012-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)-
dc.subject.classificationCàncer colorectal-
dc.subject.classificationMetàstasi-
dc.subject.otherColorectal cancer-
dc.subject.otherMetastasis-
dc.titleA Truncated Form of IKKa Is Responsible for Specific Nuclear IKK Activity in Colorectal Cancer-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec700999-
dc.date.updated2018-07-24T12:53:01Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
MargalefP.pdf2.74 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons